The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 19, 2020
Filed:
Apr. 23, 2015
Applicant:
Vitae Pharmaceuticals, Inc., Fort Washington, PA (US);
Inventors:
Salvacion Cacatian, Conshohocken, PA (US);
David A. Claremon, Maple Glen, PA (US);
Lanqi Jia, Horsham, PA (US);
Angel Morales-Ramos, Blue Bell, PA (US);
Suresh B. Singh, Kendall Park, NJ (US);
Shankar Venkatraman, Lansdale, PA (US);
Zhenrong Xu, Chalfont, PA (US);
Yajun Zheng, Hockessin, DE (US);
Assignee:
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 19/16 (2006.01); C07H 19/06 (2006.01); C07D 473/36 (2006.01); C07D 473/40 (2006.01); C07D 405/04 (2006.01); C07D 473/34 (2006.01); A61K 31/517 (2006.01); A61K 31/675 (2006.01); A61K 31/7056 (2006.01); A61K 31/7072 (2006.01); A61K 31/7076 (2006.01); A61K 45/06 (2006.01); C07D 239/72 (2006.01); C07F 9/6512 (2006.01); C07F 9/6561 (2006.01); C07H 19/052 (2006.01);
U.S. Cl.
CPC ...
C07H 19/16 (2013.01); A61K 31/517 (2013.01); A61K 31/675 (2013.01); A61K 31/7056 (2013.01); A61K 31/7072 (2013.01); A61K 31/7076 (2013.01); A61K 45/06 (2013.01); C07D 239/72 (2013.01); C07D 405/04 (2013.01); C07D 473/34 (2013.01); C07D 473/36 (2013.01); C07D 473/40 (2013.01); C07F 9/65128 (2013.01); C07F 9/65616 (2013.01); C07H 19/052 (2013.01); C07H 19/06 (2013.01);
Abstract
Provided are novel purine nucleoside/nucleotide analogues compounds, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are inhibitors of CD73 and are useful in the treatment of cancer.